IMVT position history
The shares of Immunovant (IMVT) that DME Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 93,520 shares, $2.3M, 0.07% of portfolio, New
- 2026 Q2: 93,520 shares, $3.6M, 0.09% of portfolio
- 2026 Q3: 70,140 shares, $2.4M, 0.07% of portfolio, Reduce −25.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|